Contact information
| Country: | |
|---|---|
| Tel: | 010-67887110 |
| Mobile: | 15600038801 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
Company Profile
-
Enterprise Basic Information
Enterprise Certification
 |
|
| Type of Enterprise: | Co., LTD. |
| Legal Representative: | Changru Liu |
| Registered Capital: | 42.846849 million |
| Founded Date: | 2005-04-26 |
| Registered Address: | A5, Jinghai Industrial Zone, No. 156 Jinghai 4th Road,BDA,Beijing |
| Term of Validity: | Long-term |
| Business Scope: | Beijing Hope Pharmaceutical Co., Ltd., established in 2005, is a high-tech enterprise with "chemical drug technology development-Process Optimization-Regulation registration and approval" as its core competence, and has won the title of "China Top 20 Pharmaceutical R&D Company" for several times. Hope Pharma actively builds one-stop service for drug CRO and CDMO, continuously expands its service areas, and establishes good cooperative relations with some leading pharmaceutical companies domestic and abroad. Hope Pharma has over 16 years of experience in project evaluation, innovation-oriented patent around design, pre-clinical development, clinical trial practice, registration, marker authorization, etc.. Our products involve anti-tumor, anti-depressant, anti-epileptic, anxiolytic, cardiovascular and cerebrovascular, digestive system, respiratory system and other indications. In finished products, Hope Pharma has accumulated rich experience in technical platforms such as sustained-release dosage, PLM-PtsE preparation platforms, and transdermal drug delivery, and has long-term accumulation for special reaction types (like nitrification, asymmetric catalysis, low temperature reaction) and chiral drugs. Until now, more than 100 technology transform, over 70 registration approvals and 40+ patents has been finished in Hope(including subsidiaries) for past 16 years, and has been rated as a national high-tech enterprise. Hope Pharma currently has 3 production bases, passed the on-site audit of USFDA and PMDA, and a number of products have obtained CEP certificate and USDMF number, our products well exported to Europe, Japan, South Korea, Taiwan, India and other countries and regions. |
| Staff number: | 100-500 People |
| Number of R & D department: | Above 100 |
| Annual turnover： | RMB 10 million-50 million |
| Main consumer market： | Research InstituteL Fine chemical plant Material factory Petrochemical enterprises Pharmaceutical factory |
| Main marketing location： | South Korea India Japan Vietnam Brazil |
| Main product or service： | Beijing Hope Pharmaceutical Co., Ltd., established in 2005, is a high-tech enterprise with "chemical drug technology development-Process Optimization-Regulation registration and approval" as its core |
Manufacturer
| Marketing : | Beijing Hope Pharmaceutical Co.,Ltd. |
| Address: | A5, Jinghai Industrial Zone, No. 156 Jinghai 4th Road,BDA,Beijing |
| Area: | 5200 |
| Pictures of scenes: | |
|
|
|
| Marketing : | Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. |
| Address: | HPLC, UPLC, GC, TGA, DSC, LC-MS, etc |
| Area: | 20,000sq.m. |
| Equipment: | Shenze County Industrial Park, Shijiazhuang City, |
| Pictures of scenes: | |
|
|
| Brief description : | Honor： National High-Tech Enterprise China?Top 20 Pharmaceutical R&D?Company Beijing specialized and special new enterprises Beijing Science and Technology Research and Development Organization Beijing Yizhuang Enterprise Innovation Center Patent： In 2023 new patent application: 9 Total patent application: 61 Issued Patents: 16 Our products related to multiple indications such as Anti-tumor, Anti-depression, Anti-epileptic, Anti-anxiety, Cardiovascular, Cerebrovascular, Digestive & Respiratory |
| Quality inspection equipment: | HPLC, UPLC, GC, TGA, DSC, LC-MS, etc |
|
|
| Certificate of accreditation: | CNAS Certificate |
|
|
| Brief description : | Hope Pharma as the holder of technology, intellectual property rights and DMF, we entrust the 3rd party to produce intermediates and APIs through MAH model, and achieve mutual benefit and win-win results through strategic cooperation and mutual shareholding. Location: Chongqing Changshou, National Park Leading CDMO site for API and intermediate products, service for Johnson & Johnson, Pfizer, Novartis, Roche Comply with cGMP and EHS request for API and intermediate with large scale Approved USF |
| Pictures of scenes: | |
|
|
|
| Staff composition for example: | |
| Professional skills: | |
| Pictures of scenes: | |